American International Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-453,514
| Closed | -$82.6M | – | 11 |
|
|
2024
Q1 | $82.6M | Sell |
453,514
-2,749
| -0.6% | -$474K | 0.3% | 30 |
|
|
2023
Q4 | $70.7M | Sell |
456,263
-8,572
| -2% | -$1.25M | 0.29% | 32 |
|
|
2023
Q3 | $69.3M | Sell |
464,835
-7,542
| -2% | -$1.11M | 0.45% | 26 |
|
|
2023
Q2 | $63.6M | Buy |
472,377
+6,311
| +1% | +$925K | 0.39% | 28 |
|
|
2023
Q1 | $74.3M | Buy |
466,066
+2,327
| +0.5% | +$356K | 0.49% | 23 |
|
|
2022
Q4 | $74.9M | Sell |
463,739
-9,592
| -2% | -$1.47M | 0.52% | 24 |
|
|
2022
Q3 | $63.5M | Sell |
473,331
-11,506
| -2% | -$1.65M | 0.46% | 25 |
|
|
2022
Q2 | $74.3M | Sell |
484,837
-13,765
| -3% | -$2.1M | 0.5% | 24 |
|
|
2022
Q1 | $80.8M | Sell |
498,602
-14,205
| -3% | -$2.06M | 0.44% | 26 |
|
|
2021
Q4 | $69.4M | Sell |
512,807
-3,192
| -0.6% | -$377K | 0.35% | 42 |
|
|
2021
Q3 | $55.7M | Sell |
515,999
-25,981
| -5% | -$2.97M | 0.3% | 47 |
|
|
2021
Q2 | $61K | Sell |
541,980
-10,501
| -2% | -$1.18M | 0.21% | 88 |
|
|
2021
Q1 | $59.8K | Sell |
552,481
-11,220
| -2% | -$1.2M | 0.21% | 81 |
|
|
2020
Q4 | $60.4K | Sell |
563,701
-2,130,946
| -79% | -$205M | 0.22% | 74 |
|
|
2020
Q3 | $236M | Sell |
2,694,647
-459,158
| -15% | -$43.2M | 1.13% | 11 |
|
|
2020
Q2 | $310M | Sell |
3,153,805
-226,424
| -7% | -$19.9M | 1.49% | 4 |
|
|
2020
Q1 | $258M | Sell |
3,380,229
-1,175,771
| -26% | -$100M | 1.41% | 10 |
|
|
2019
Q4 | $403M | Buy |
4,556,000
+325,232
| +8% | +$27M | 1.56% | 8 |
|
|
2019
Q3 | $320M | Sell |
4,230,768
-151,493
| -3% | -$10.4M | 1.29% | 25 |
|
|
2019
Q2 | $319M | Sell |
4,382,261
-296,589
| -6% | -$23.3M | 1.25% | 25 |
|
|
2019
Q1 | $377M | Sell |
4,678,850
-228,016
| -5% | -$18.7M | 1.43% | 24 |
|
|
2018
Q4 | $452M | Sell |
4,906,866
-249,679
| -5% | -$22M | 1.86% | 9 |
|
|
2018
Q3 | $488M | Sell |
5,156,545
-145,023
| -3% | -$13.8M | 1.62% | 16 |
|
|
2018
Q2 | $491M | Sell |
5,301,568
-234,339
| -4% | -$22.9M | 1.71% | 17 |
|
|
2018
Q1 | $524M | Sell |
5,535,907
-60,939
| -1% | -$6.69M | 1.83% | 13 |
|
|
2017
Q4 | $541M | Sell |
5,596,846
-2,141,066
| -28% | -$202M | 1.78% | 18 |
|
|
2017
Q3 | $688M | Sell |
7,737,912
-35,461
| -0.5% | -$2.7M | 2.43% | 2 |
|
|
2017
Q2 | $564M | Buy |
7,773,373
+5,727
| +0.1% | +$385K | 2.01% | 7 |
|
|
2017
Q1 | $506M | Buy |
7,767,646
+87,678
| +1% | +$5.51M | 1.85% | 18 |
|
|
2016
Q4 | $481M | Buy |
7,679,968
+6,978,838
| +995% | +$426M | 1.86% | 16 |
|
|
2016
Q3 | $44.2M | Buy |
701,130
+3,096
| +0.4% | +$200K | 0.18% | 62 |
|
|
2016
Q2 | $43.2M | Sell |
698,034
-137,822
| -16% | -$8.4M | 0.18% | 59 |
|
|
2016
Q1 | $47.7M | Sell |
835,856
-25,510
| -3% | -$1.42M | 0.19% | 60 |
|
|
2015
Q4 | $51M | Buy |
861,366
+45,728
| +6% | +$2.63M | 0.21% | 62 |
|
|
2015
Q3 | $44.4M | Sell |
815,638
-16,431
| -2% | -$1.07M | 0.19% | 59 |
|
|
2015
Q2 | $55.9M | Buy |
832,069
+55,263
| +7% | +$3.61M | 0.22% | 55 |
|
|
2015
Q1 | $45.5M | Sell |
776,806
-5,035
| -0.6% | -$304K | 0.19% | 60 |
|
|
2014
Q4 | $51.2M | Sell |
781,841
-6,728
| -0.9% | -$424K | 0.22% | 53 |
|
|
2014
Q3 | $45.5M | Buy |
788,569
+6,490
| +0.8% | +$360K | 0.2% | 57 |
|
|
2014
Q2 | $44.1M | Buy |
782,079
+15,745
| +2% | +$826K | 0.19% | 54 |
|
|
2014
Q1 | $39.4M | Buy |
766,334
+2,441
| +0.3% | +$123K | 0.19% | 58 |
|
|
2013
Q4 | $40.3M | Buy |
763,893
+6,153
| +0.8% | +$302K | 0.19% | 59 |
|
|
2013
Q3 | $33.9M | Buy |
757,740
+4,297
| +0.6% | +$190K | 0.18% | 65 |
|
|
2013
Q2 | $31.1M | Buy |
+753,443
| New | +$33M | 0.19% | 67 |
|
Other funds holding ABBV
American International Group's ABBV Position: Q2 2024 in Review
American International Group sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 453,514 shares — an estimated $82.6M sold.
American International Group first reported a position in ABBV in Q2 2013 and held it in 44 quarters. The position peaked at $688M in Q3 2017. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.
- American International Group reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
- American International Group sold 453,514 AbbVie shares in Q2 2024, an estimated $82.6M.
- American International Group first reported a position in AbbVie in Q2 2013 and held it in 44 quarters.
- American International Group's AbbVie position peaked at $688M in Q3 2017.
- 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.